EUVIMEDPoznaj EUVIMED
Crossref

The Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications

Karla Leslie Martínez Hernández, Montserrat Peña Plascencia, Nathy Rodriguez Pequeño, Hillary Yahiry Mejía Montiel, Gendy Mellisa Mojica Barreneche, José Arnulfo Perez Carillo, Dominique Magdalena Nathan Kreisberg, Jorge Angel Velasco Espinal

International Science Journal · 2026-05-01 · 3 (1)

DOI: 10.64784/193 ↗

At a glance

Journal article in International Science Journal, published online on 2026-05-01. Written by Karla Leslie Martínez Hernández and 7 co-authors.

AbstraktDane bibliograficzneCiteRelated studies

Abstract (original language)

The skin microbiome has emerged as a key regulator of immune function with significant implications for systemic disease. This review aims to analyze the role of cutaneous microbial communities in immune modulation and their contribution to the development, diagnosis, and treatment of systemic conditions. A structured narrative review was conducted using a scientific methodological framework, integrating evidence from dermatology, immunology, and microbiology. The findings indicate that microbial dysbiosis is consistently associated with immune imbalance, barrier dysfunction, and systemic inflammation. Key mechanisms include Toll-like receptor activation, cytokine modulation, and T-cell differentiation, which collectively influence disease progression. Additionally, the study highlights the growing relevance of the gut-skin axis as a pathway connecting local microbial changes with systemic outcomes. Diagnostic applications, particularly microbiome-based biomarkers, demonstrate potential for disease prediction and monitoring, while therapeutic strategies such as probiotics, bacteriotherapy, and antimicrobial peptides represent emerging approaches in personalized medicine. However, variability across populations and methodological heterogeneity remain significant challenges. This review underscores the importance of the skin microbiome as a central component in human health and supports its integration into future clinical and research frameworks, particularly in diverse international contexts..

Cite

APA

Hernández, K. L. M., Plascencia, M. P., Pequeño, N. R., Montiel, H. Y. M., Barreneche, G. M. M., Carillo, J. A. P., Kreisberg, D. M. N., & Espinal, J. A. V. (2026). The Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications. International Science Journal, 3(1). https://doi.org/10.64784/193

Vancouver

Hernández KLM, Plascencia MP, Pequeño NR, Montiel HYM, Barreneche GMM, Carillo JAP, et al. The Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications. International Science Journal. 2026;3(1). doi:10.64784/193

BibTeX
@article{Hernndez2026,
  author = {Hernández, Karla Leslie Martínez and Plascencia, Montserrat Peña and Pequeño, Nathy Rodriguez and Montiel, Hillary Yahiry Mejía and Barreneche, Gendy Mellisa Mojica and Carillo, José Arnulfo Perez and Kreisberg, Dominique Magdalena Nathan and Espinal, Jorge Angel Velasco},
  title = {The Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications},
  journal = {International Science Journal},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.64784/193}
}
Start for free →